Skip to content
WeighLab
Menu
Ranked #187 · Grade C

Harbor review

Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

Visit Harbor Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$99/mo (starting dose, compounded)
Tirzepatide
$149/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$1,188

Tirzepatide · modeled / year

$1,788

The Index scorecard

Harbor scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month70/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight90/100
Contract Flexibility47/100

Where the value is

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

The tradeoffs

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified

The bottom line

Best for: Cost-first shoppers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

Ranked #187 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Harbor.

The 18 programs nearest this one

Pricing, states and verification reflect Harbor's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Harbor's site. Not medical advice; see our disclosure.

← Back to the value leaderboard